sobuzoxane has been researched along with Diffuse Large B-Cell Lymphoma in 3 studies
sobuzoxane: used in treatment of leukemia L1210
Excerpt | Relevance | Reference |
---|
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tsunoda, S | 1 |
Kobayashi, H | 1 |
Inoue, K | 1 |
Izumi, T | 1 |
Akutsu, M | 1 |
Katano, S | 1 |
Ueda, T | 1 |
Shirai, T | 1 |
Masuda, Y | 1 |
Ohmine, K | 1 |
Nagashima, T | 1 |
Ueda, M | 1 |
Takagi, S | 1 |
Muroi, K | 1 |
Ozawa, K | 1 |
Kano, Y | 1 |
Okamoto, T | 2 |
Nishimura, Y | 1 |
Yamada, S | 2 |
Itoh, T | 1 |
Mori, A | 2 |
Saheki, K | 1 |
Okada, M | 2 |
Takatsuka, H | 2 |
Wada, H | 1 |
Tamura, A | 1 |
Fujimori, Y | 1 |
Kakishita, E | 2 |
Wakae, T | 1 |
3 other studies available for sobuzoxane and Diffuse Large B-Cell Lymphoma
Article | Year |
---|---|
[MTX-HOPE (methotrexate, hydrocortisone, vincristine, sobuzoxane, and etoposide) as a low-dose salvage chemotherapy for recurrent or refractory non-Hodgkin's lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relati | 2007 |
Long-term administration of oral low-dose topoisomerase II inhibitors, MST-16 and VP-16, for refractory or relapsed non-Hodgkin's lymphoma.
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Sch | 2000 |
Secondary acute promyelocytic leukemia in a patient with non-Hodgkin's lymphoma treated with VP-16 and MST-16.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Cytarabin | 2002 |